Rheumatology Therapeutics Market - Global Industry
Insights, Trends, Outlook, and Opportunity Analysis,
2018-2026
Rheumatology diseases affects the supporting or connecting structures of the body mostly joints,
ligaments, muscles, tendons, and rarely some organs of the body. This disease is characterized
by inflammation of joints and it affects spine in some types of rheumatology disease. There are
more than 100 types of rheumatic disease. It is caused by various genetic and environmental
factors, such as unhealthy diet and changing lifestyle, which can lead to rheumatology diseases.
Osteoarthritis, ankylosing spondylitis, rheumatoid arthritis, gout, psoriatic arthritis, reactive
arthritis, fibromyalgia, and scleroderma are some of the common types of rheumatology
diseases. Rheumatology treatment involves medications, exercises, and physical therapies with
surgical treatment to cure joint damage. Early treatment can be beneficial for treatment of
rheumatologic symptoms. Physicians prescribe disease-modifying antirheumatic drugs (DMARD’s)
for the treatment of rheumatologic disease. Sufficient nutrition, proper exercise, and medications
can help to cure rheumatology diseases.
Request Sample Copy of Research Report @
https://www.coherentmarketinsights.com/insight/request-sample/796
Increasing burden of rheumatology diseases globally is propelling the growth of rheumatology
therapeutics market
The increase in population with some sort of rheumatology arthritis globally is major driving
factor for the rheumatology therapeutics market. According to data given by Centers for Disease
Control and Prevention (CDC) in 2013, around 52.5 million of adults in the U.S. have suffered
from rheumatology arthritis, which equals to 23% of the population with 1% being the
prevalence rate of rheumatology diseases globally. According to the Global Burden of Disease
2010 study data, prevalence rate for knee arthritis globally was 3.8% and for hip osteoarthritis
was 0.85% globally. Additionally, technological advancements in medical field, investments in
the healthcare sector over research and development, and rising trend of fitness are important
factors contributing to the growth of rheumatology therapeutics market. According to the World
Health Organization (WHO) in 2014, government spent 15.5% on healthcare sector.